In the first segment of this one-on-one interview series, Peter Salgo, MD, and Irwin W. Tischler, DO, discuss major innovations in the treatment of cancer. Drs Salgo and Tischler also discuss the 21st Century Cures initiative recently launched by the US Congress.
Dr Tischler, a national medical director of oncology for Cigna, says that the use of molecular profiling and targeted therapy have been a “tremendous boon” in the treatment of cancer over the past decade. Targeted therapies make possible the personalization of treatment based on specific genetic abnormalities and are also associated with a lower incidence of side effects.
Next, Drs Salgo and Tischler discuss the 21st Century Cures initiative, recently launched by the US Congress. It is expected that this initiative will help address various barriers to the development of new treatment options.
The initiative is designed to allow various stakeholders in healthcare to share their opinions about how to accelerate the pace of healthcare innovation in the United States, Dr Tischler remarks. The initiative is attempting to eliminate regulatory barriers that have impeded innovation in the past. Use of a comprehensive team approach is expected to help launch new drugs and devices in a more timely fashion.
Dr Tischler predicts that there will be a rapid acceleration of the pace of innovation, especially if the initiative helps lower the costs that are currently associated with research and development by pharmaceutical companies.
Oncology Stakeholder Summit 2014: Evidence-Based Decisions to Improve Quality and Regulate Costs
Watch our related Peer Exchange,
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More